Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for recurrence and survival in stage II and III colon cancer
NL-OMON50659Phase 3Completed
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colon cancer and colon adenocarcinoma comparing Aspirin with Placebo (2 arms). Primary endpoint: Five-year overall survival. Started Jan 2015; status: completed.
02
Drugs
aspirin
03
Conditions
colon cancercolon adenocarcinoma
Beyond the preview
Go deeper on NL-OMON50659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50659.